FDA Warning on Olmesartan Medoxomil - Joseph Murray, M.D.

Mayo Clinic gastroenterologist and celiac disease expert Joseph Murray, M.D., discusses the recent warning issued by the FDA the blood pressure drug known generically as olmesartan medoxomil. The drug can cause intestinal problems known as spruelike enteropathy, which has side effects including severe, chronic diarrhea and substantial weight loss, sometimes requiring hospitalization

For more information on the warning visit: http://www.mayoclinic.org/news2013-rs...

• #science_technology
• #mayo_clinic
• #healthcare
• #health_care
• #celiac_disease
• #sprue
• #coeliac
• #olmesartan
• #fda_warning
• #blood_pressure_medication
• #benicar
• #spruelike_enteropathy
• #mayo_clinic_proceedings
• #drug_adverse_event_reporting